Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro

Toxicological Sciences

Volumn 69, Issue 2, 2002, Pages 354-361

  Goodin, M G ^a   Fertuck, K C ^b   Zacharewski, T R ^b   Rosengren, R J ^a,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Michigan State University   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Catechins; ECG; EGC; EGCG; ER ; ER ; Human breast cancer cells

Indexed keywords

CATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GALACTOSIDASE; GLUTATHIONE; LUCIFERASE; PEROXIDASE; POLYPHENOL DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CHIMERA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMATURITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN DOMAIN; RECEPTOR BINDING; REPORTER GENE; UTERUS WEIGHT;

ANIMALS; BINDING, COMPETITIVE; BODY WEIGHT; CATECHIN; CELL SURVIVAL; CELLS, CULTURED; CYTOSOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FLAVONOIDS; GENES, REPORTER; HEPATITIS, TOXIC; HUMANS; LIVER; MICE; MICE, INBRED C57BL; ORGAN SIZE; PEROXIDASES; PHENOLS; POLYMERS; RECEPTORS, ESTROGEN; TRANSFECTION; UTERUS;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0036772832     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/69.2.354     Document Type: Article

References (37)

1. Anzick, S. L., Kononen, J. K., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., and Meltzer, P. S. (1997). AlB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277, 965-968.
2. Arts, I. C., Hollman, P. C., and Kromhout, D. (1999). Chocolate as a source of tea flavonoids. Lancet 354, 488.
3. Arts, I. C., van de Putte, B., and Hollman, P. C. (2000). Catechin contents of foods commonly consumed in the Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J. Agric. Food Chem. 48, 1746-1751.
4. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Brasier, A. R., Tate, J. E., and Habener, J. F. (1989). Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7, 1116-1122.
6. Breinholt, V., and Larsen, J. C. (1998). Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem. Res. Toxicol. 11, 622-629.
7. Clarke, R., Brunner, N., Thompson, E. W., Glanz, P., Zatz, D., Dickson, R. B., and Lippman, M. E. (1989). The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer. J. Endocrinol. 122, 331-340.
8. Connor, K., Howell, J., Chen, I., Liu, H., Berhane, K., Sciarretta, S., Safe, S., and Zacharewski, T. (1996). Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam. Appl. Toxicol. 30, 93-101.
9. Damianaki, A., Bakogeorgou, E., Kampa, M., Notas, G., Hatzoglou, A., Panagiotou, S., Gemetzi, C., Kouroumalis, E., Martin, P. M., and Castanas, E. (2000). Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell. Biochem. 78, 429-441.
10. Fang, H., Tong, W., Shi, L. M., Blair, R., Perkins, R., Branham, W., Hass, B. S., Xie, Q., Dial, S. L., Moland, C. L., and Sheehan, D. M. (2001). Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol. 14, 280-294.
11. Fertuck, K. C., Matthews, J. B., and Zacharewski, T. R. (2001). Hydroxylated benzo[a]pyrene are responsible for in vitro estrogen receptor-mediated gene expression of benzo[a]pyrene, but do not elicit uterotrophic effects in vivo. Toxicol. Sci. 59, 231-240.
12. Hirose, M., Hoshiya, T., Akagi, K., Futakuchi, M., and Ito, N. (1994). Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[a]anthracene. Cancer Lett. 83, 149-156.
13. Ikigai, H., Nakae, T., Hara, Y., and Shimamura, T. (1993). Bactericidal catechins damage the lipid bilayer. Biochim. Biophys. Acta 1147, 132-136.
14. Kalkhoven, E., Valentine, J. E., Heery, D. M., and Parker, M. G. (1998). Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. Embo J. 17, 232-243.
15. Kao, Y.-H., Hiipakka, R. A., and Liao, S. (2000). Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141, 980-987.
16. Kavanagh, K. T., Hafer, L. J., Kim, D. W., Man, K. K., Sherr, D. H., Rogers, A. E., and Sonenshein, G. E. (2001). Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell. Biochem. 82, 387-398.
17. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252-4263.
18. Kuruto-Niwa, R., Inoue, S., Ogawa, S., Muramatsu, M., and Nozawa, R. (2000). Effects of tea catechins on the ERE-regulated estrogenic activity. J. Agric. Food Chem. 48, 6355-6361.
19. Liao, S., Umekita, Y., Guo, J., Kokontis, J. M., and Hiipakka, R. A. (1995). Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 96, 239-243.
20. Matthews, J., and Zacharewski, T. (2000). Differential binding affinities of PCBs, HO-PCBs, and aroclors with recombinant human, rainbow trout (Onchorhynkiss mykiss) and green anole (Anolis carolinensis) estrogen receptors, using a semi-high throughput competitive binding assay. Toxicol. Sci. 53, 326-339.
21. Morre, D. J., Bridge, A., Wu, L.-Y., and Morre, D. M. (2000). Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth transformed cells in culture. Biochem. Pharmacol. 60, 937-946.
22. Mukhtar, H., Wang, Z. Y., Katiyar, S. K., and Agarwal, R. (1992). Tea components: Antimutagenic and anticarcinogenic effects. Prev. Med. 21, 351-360.
23. Muto, S., Fujita, K., Yamazaki, Y., and Kamataki, T. (2001). Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 479, 197-206.
24. Nakachi, K., Suemasu, K., Suga, K., Takeo, T., Imai, K., and Higashi, Y. (1998). Influence of drinking tea on breast cancer malignancy among Japenese patients. Japan. J. Cancer Res. 89, 254 -261.
25. Nakayama, T., Hashimoto, T., Kajiya, K., and Kumazawa, S. (2000). Affinity of polyphenols for lipid bilayers. Biofact. 13, 147-151.
26. 3-450: Enzymatic characterization of the hemoprotein expressed in human cells infected with recombinant vaccinia virus. Acta Med. Okayama 47, 377-382.
27. Patel, R., and Rosengren, R. J. (2001). Acetaminophen elicits anti-estrogenic but not estrogenic responses in the immature mouse model. Toxicol. Lett. 1220, 89-96.
28. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Plainview, NY.
29. Sheehan, D. M., Branham, W. S., and Medlock, K. L. (1995). An estrogen development potency and toxicity assay for environmental estrogens. Teratology 51, 196-197.
30. Spink, D. C., Spink, B. C., Cao, J. Q., DePasquale, J. A., Pentecost, B. T., Fasco, M. J., Li, Y., and Sutter, T. R. (1998). Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19, 291-298.
31. Stoner, G. D., and Mukhtar, H. (1995). Polyphenols as cancer chemopreventive agents. J. Cell. Biochem. 22, 169-180.
32. Suganuma, M., Okabe, S., Sueoka, N., Sueoka, E., Matsuyama, S., Imai, K., Nakachi, K., and Fujiki, H. (1999). Green tea and cancer chemoprevention. Mutat. Res. 428, 339-344.
33. Tedesco, R., Katzenellenbogen, J. A., and Napolitano, E. (1997). 7α,11β-Disubstituted estrogens: Probes for the shape of the ligand binding pocket in the estrogen receptor. Bioorgan. Med. Chem. Lett. 7, 2919-2924.
34. Valcic, S., Timmermann, B. N., Alberts, D. S., Wachter, G. A., Krutzsch, M., Wymer, J., and Guillen, J. M. (1996). Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. AntiCancer Drugs 7, 461-468.
35. Villalobos, M., Olea, N., Brotons, J. A., Olea-Serrano, M. F., Ruiz de Almodovar, J. M., and Pedraza, V. (1995). The E-screen assay: A comparison of different MCF7 cell stocks. Environ. Health Perspect. 103, 844-450.
36. Wang, Z. Y., Das, M., Bickers, D. R., and Mukhtar, H. (1988). Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450. Drug. Metab. Disp. 16, 98-103.
37. Zhu, B. T., and Conney, A. H. (1998). Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 58, 2269-2277.